Carregant...
The impact of FDA and EMEA guidelines on drug development in relation to Phase 0 trials
An increase in the number of identified therapeutic cancer targets achieved through recent biomedical research has resulted in the generation of a large number of molecules that need to be tested further. Current development of (anticancer) drugs is a rather inefficient process that for an average n...
Guardat en:
| Autors principals: | , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Nature Publishing Group
2007
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2360360/ https://ncbi.nlm.nih.gov/pubmed/17726450 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6603925 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|